/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

G

Geke A.P. Hospers

University Medical Center Groningen(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

563

Papers

24.8K

Citations

62

h-index

212

i10-index

Geke A.P. Hospers is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management & CAR-T cell therapy research. The author has an h-index of 62, co-authored 479 publications.

ORCID: 0000-0002-3047-7892

Research Topics

Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management CAR-T cell therapy research Melanoma and MAPK Pathways Colorectal Cancer Treatments and Studies

Papers by this author

works

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

2020 · The Lancet Oncology · 1,545 citations

https://doi.org/10.1016/s1470-2045(20)30555-6

Renu R. Bahadoer Esmée A. Dijkstra Boudewijn van Etten Corrie A.M. Marijnen

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

2021 · Journal of Clinical Oncology · 732 citations

https://doi.org/10.1200/jco.20.03614

Ben M. Eyck J. Jan B. van Lanschot Maarten C.C.M. Hulshof Berend J. van der Wilk

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

2022 · Nature Medicine · 403 citations

https://doi.org/10.1038/s41591-022-01695-5

Karla A. Lee Andrew Maltez Thomas Laura A. Bolte Johannes R. Björk

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

2022 · Nature Medicine · 332 citations

https://doi.org/10.1038/s41591-022-01851-x

Irene L. M. Reijers Alexander M. Menzies Alexander C. J. van Akkooi Judith M. Versluis

Molecular imaging of breast cancer

2009 · The Breast · 97 citations

https://doi.org/10.1016/s0960-9776(09)70276-0

Thijs H. Oude Munnink Wouter B. Nagengast Adrienne H. Brouwers C.P. Schröder

Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma

2020 · Melanoma Research · 78 citations

https://doi.org/10.1097/cmr.0000000000000656

Thijs T. Wind Ranko Gaćeša Arnau Vich Vila Jacco J. de Haan

Research topics

topics

Cancer Immunotherapy and Biomarkers

Cutaneous Melanoma Detection and Management

CAR-T cell therapy research

Melanoma and MAPK Pathways

Colorectal Cancer Treatments and Studies

Chat about Author

Papers

Chat

Click to start Chat